There is a lack of subcutaneous anticoagulant counseling tools for COVID-19 patients. This study aims to develop and validate a written counseling tool for subcutaneous anticoagulant use in COVID-19 patients. A prospective cohort study was performed with expert panels and patients. The tool was validated by hospital pharmacists using Content Validity Index (I-CVI), Scale-level-CVI (S-CVI), and Universal Acceptance (UA). Face validation by patients was determined using Item Acceptance Index (IAI)
No takes yet. Share an insight, caveat, or question.
Low et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: